TEN TWELVE

Brand Owner (click to sort) Address Description
10 TO 12 AMANDA SHI 2225 Malaga Road Los Angeles CA 90068 TEN TO TWELVE;Baby blankets; Burp cloths; Cashmere blankets; Children's blankets; Nursing covers; Swaddling blankets; Fabric drapes designed to conceal the act of breastfeeding in public;
10 TO 12 10 TO 12 2225 Malaga Road Los Angeles CA 90068 TEN TO TWELVE;Booties; Children's headwear; Children's underwear; Children's and infant's apparel, namely, jumpers, overall sleepwear, pajamas, rompers and one-piece garments; Children's and infants' cloth bibs; Hats for infants, babies, toddlers and children; Infant sleepers; Infant wear; Infant wearable blankets; Infant and toddler one piece clothing; Plastic baby bibs; Children's and infants' apparel treated with fire and heat retardants, namely, jumpers, overall sleepwear, pajamas, rompers and one-piece garments;
TEN12 Ten12 700 Canal St. Stamford CT 06902 TEN TWELVE; TEN ONE TWO;Provision of data and analysis relating to the finance industry, namely, providing financial analysis, in the nature of compiling and analyzing statistics, data and other sources of information for financial purposes;Application service provider featuring application programming interface (API) software for the provision of data and analysis relating to the finance industry;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention is directed to a method to prevent or reduce postoperative corneal subepithelial haze after excimer laser photorefractive keratectomy (PRK), laser in situ keratomileusis (LASIK) surgery. According to the method, a therapeutically effective amount of one or more plasminogen activators, most preferably urokinase (uPA), is administered topically to the surface of the affected eye at levels between 0.1 and 2,500 IU/ml, about eight to twelve times on the day of surgery, and four to eight times per day for about the next six to twelve days thereafter. The most preferred therapeutic amount is from about 0.1-1 IU uPA/ml, and also 1-10 IU/ml. Plasminogen activators that can be used in the inventions include urokinase, prourokinase, streptokinase and mutants thereof. The invention also covers topical ophthalmic compositions that include one or more plasminogen activators, most preferably uPA, to prevent or reduce postoperative corneal subepithelial haze.